NEW YORK (GenomeWeb) – Developer of rapid, multiplex molecular diagnostics, Qvella, has raised $20 million in Series B financing, the company said today.

The funding round was co-led by the firm's existing investor syndicate, including RA Capital, Whitecap Venture Partners, Hatteras Ventures, and Sands Capital, which previously supplied Qvella $20 million in Series A financing. New investor BioMérieux also participated in the round.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.